nodes	percent_of_prediction	percent_of_DWPC	metapath
Ixabepilone—TUBB2A—Signaling events mediated by HDAC Class III—HOXA10—uterine cancer	0.019	0.107	CbGpPWpGaD
Ixabepilone—TUBB4B—oviduct—uterine cancer	0.0168	0.0606	CbGeAlD
Ixabepilone—TUBB1—decidua—uterine cancer	0.0082	0.0296	CbGeAlD
Ixabepilone—TUBB2B—myometrium—uterine cancer	0.00665	0.024	CbGeAlD
Ixabepilone—TUBB—myometrium—uterine cancer	0.0063	0.0227	CbGeAlD
Ixabepilone—TUBB2A—myometrium—uterine cancer	0.00626	0.0226	CbGeAlD
Ixabepilone—TUBB6—myometrium—uterine cancer	0.00618	0.0223	CbGeAlD
Ixabepilone—TUBB4B—myometrium—uterine cancer	0.00537	0.0194	CbGeAlD
Ixabepilone—TUBB4A—uterine cervix—uterine cancer	0.00536	0.0193	CbGeAlD
Ixabepilone—TUBB2B—uterine cervix—uterine cancer	0.00518	0.0187	CbGeAlD
Ixabepilone—TUBB4A—renal system—uterine cancer	0.00501	0.0181	CbGeAlD
Ixabepilone—TUBB—uterine cervix—uterine cancer	0.0049	0.0177	CbGeAlD
Ixabepilone—TUBB2A—uterine cervix—uterine cancer	0.00487	0.0176	CbGeAlD
Ixabepilone—TUBB6—epithelium—uterine cancer	0.00485	0.0175	CbGeAlD
Ixabepilone—TUBB2B—renal system—uterine cancer	0.00484	0.0175	CbGeAlD
Ixabepilone—TUBB6—uterine cervix—uterine cancer	0.00481	0.0173	CbGeAlD
Ixabepilone—TUBB—smooth muscle tissue—uterine cancer	0.00476	0.0172	CbGeAlD
Ixabepilone—TUBB2A—smooth muscle tissue—uterine cancer	0.00474	0.0171	CbGeAlD
Ixabepilone—TUBB2B—endometrium—uterine cancer	0.00468	0.0169	CbGeAlD
Ixabepilone—TUBB6—smooth muscle tissue—uterine cancer	0.00467	0.0169	CbGeAlD
Ixabepilone—TUBB—decidua—uterine cancer	0.00467	0.0168	CbGeAlD
Ixabepilone—TUBB2A—decidua—uterine cancer	0.00464	0.0168	CbGeAlD
Ixabepilone—TUBB6—decidua—uterine cancer	0.00458	0.0165	CbGeAlD
Ixabepilone—TUBB2B—mammalian vulva—uterine cancer	0.00453	0.0163	CbGeAlD
Ixabepilone—TUBB6—renal system—uterine cancer	0.0045	0.0162	CbGeAlD
Ixabepilone—TUBB4A—uterus—uterine cancer	0.00447	0.0161	CbGeAlD
Ixabepilone—TUBB—endometrium—uterine cancer	0.00443	0.016	CbGeAlD
Ixabepilone—TUBB2A—endometrium—uterine cancer	0.00441	0.0159	CbGeAlD
Ixabepilone—TUBB6—endometrium—uterine cancer	0.00435	0.0157	CbGeAlD
Ixabepilone—TUBB—mammalian vulva—uterine cancer	0.00429	0.0155	CbGeAlD
Ixabepilone—TUBB2A—mammalian vulva—uterine cancer	0.00426	0.0154	CbGeAlD
Ixabepilone—TUBB6—mammalian vulva—uterine cancer	0.00421	0.0152	CbGeAlD
Ixabepilone—TUBB4B—uterine cervix—uterine cancer	0.00418	0.0151	CbGeAlD
Ixabepilone—TUBB—uterus—uterine cancer	0.00408	0.0147	CbGeAlD
Ixabepilone—TUBB2A—uterus—uterine cancer	0.00406	0.0147	CbGeAlD
Ixabepilone—TUBB4B—smooth muscle tissue—uterine cancer	0.00406	0.0147	CbGeAlD
Ixabepilone—TUBB4A—female reproductive system—uterine cancer	0.00401	0.0145	CbGeAlD
Ixabepilone—TUBB6—uterus—uterine cancer	0.00401	0.0145	CbGeAlD
Ixabepilone—TUBB8—Parkin-Ubiquitin Proteasomal System pathway—FBXW7—uterine cancer	0.004	0.0225	CbGpPWpGaD
Ixabepilone—TUBB4B—decidua—uterine cancer	0.00398	0.0144	CbGeAlD
Ixabepilone—TUBB4B—renal system—uterine cancer	0.00391	0.0141	CbGeAlD
Ixabepilone—TUBB2B—female reproductive system—uterine cancer	0.00388	0.014	CbGeAlD
Ixabepilone—TUBB4B—endometrium—uterine cancer	0.00378	0.0136	CbGeAlD
Ixabepilone—TUBB4B—mammalian vulva—uterine cancer	0.00366	0.0132	CbGeAlD
Ixabepilone—TUBB4A—female gonad—uterine cancer	0.00365	0.0132	CbGeAlD
Ixabepilone—TUBB2A—female reproductive system—uterine cancer	0.00365	0.0132	CbGeAlD
Ixabepilone—TUBB6—female reproductive system—uterine cancer	0.0036	0.013	CbGeAlD
Ixabepilone—TUBB2B—female gonad—uterine cancer	0.00353	0.0127	CbGeAlD
Ixabepilone—TUBB2B—vagina—uterine cancer	0.00351	0.0127	CbGeAlD
Ixabepilone—TUBB4B—uterus—uterine cancer	0.00348	0.0126	CbGeAlD
Ixabepilone—TUBB—female gonad—uterine cancer	0.00334	0.0121	CbGeAlD
Ixabepilone—TUBB2A—female gonad—uterine cancer	0.00332	0.012	CbGeAlD
Ixabepilone—TUBB—vagina—uterine cancer	0.00332	0.012	CbGeAlD
Ixabepilone—TUBB2A—vagina—uterine cancer	0.0033	0.0119	CbGeAlD
Ixabepilone—TUBB6—female gonad—uterine cancer	0.00328	0.0118	CbGeAlD
Ixabepilone—TUBB6—vagina—uterine cancer	0.00326	0.0118	CbGeAlD
Ixabepilone—TUBB2A—Signaling events mediated by HDAC Class II—YWHAE—uterine cancer	0.00321	0.0181	CbGpPWpGaD
Ixabepilone—TUBB4B—female reproductive system—uterine cancer	0.00313	0.0113	CbGeAlD
Ixabepilone—TUBB4B—female gonad—uterine cancer	0.00285	0.0103	CbGeAlD
Ixabepilone—TUBB4B—vagina—uterine cancer	0.00283	0.0102	CbGeAlD
Ixabepilone—TUBB2B—Chaperonin-mediated protein folding—FBXW7—uterine cancer	0.00269	0.0152	CbGpPWpGaD
Ixabepilone—TUBB6—Chaperonin-mediated protein folding—FBXW7—uterine cancer	0.00269	0.0152	CbGpPWpGaD
Ixabepilone—TUBB3—Chaperonin-mediated protein folding—FBXW7—uterine cancer	0.0026	0.0146	CbGpPWpGaD
Ixabepilone—TUBB2A—Chaperonin-mediated protein folding—FBXW7—uterine cancer	0.00251	0.0142	CbGpPWpGaD
Ixabepilone—TUBB8—Pathogenic Escherichia coli infection—CDH1—uterine cancer	0.00246	0.0139	CbGpPWpGaD
Ixabepilone—TUBB1—Chaperonin-mediated protein folding—FBXW7—uterine cancer	0.00246	0.0139	CbGpPWpGaD
Ixabepilone—TUBB2B—Protein folding—FBXW7—uterine cancer	0.00245	0.0138	CbGpPWpGaD
Ixabepilone—TUBB6—Protein folding—FBXW7—uterine cancer	0.00245	0.0138	CbGpPWpGaD
Ixabepilone—TUBB3—Protein folding—FBXW7—uterine cancer	0.00237	0.0133	CbGpPWpGaD
Ixabepilone—TUBB4A—lymph node—uterine cancer	0.00235	0.00847	CbGeAlD
Ixabepilone—TUBB—Loss of Nlp from mitotic centrosomes—YWHAE—uterine cancer	0.00233	0.0131	CbGpPWpGaD
Ixabepilone—TUBB2A—Protein folding—FBXW7—uterine cancer	0.00229	0.0129	CbGpPWpGaD
Ixabepilone—TUBB2B—lymph node—uterine cancer	0.00227	0.00819	CbGeAlD
Ixabepilone—TUBB1—Protein folding—FBXW7—uterine cancer	0.00224	0.0126	CbGpPWpGaD
Ixabepilone—TUBB4A—Chaperonin-mediated protein folding—FBXW7—uterine cancer	0.00221	0.0124	CbGpPWpGaD
Ixabepilone—TUBB—lymph node—uterine cancer	0.00215	0.00775	CbGeAlD
Ixabepilone—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.00214	0.012	CbGpPWpGaD
Ixabepilone—TUBB2A—lymph node—uterine cancer	0.00214	0.00771	CbGeAlD
Ixabepilone—TUBB6—lymph node—uterine cancer	0.00211	0.0076	CbGeAlD
Ixabepilone—TUBB—Centrosome maturation—YWHAE—uterine cancer	0.00207	0.0116	CbGpPWpGaD
Ixabepilone—TUBB6—Parkin-Ubiquitin Proteasomal System pathway—FBXW7—uterine cancer	0.00202	0.0114	CbGpPWpGaD
Ixabepilone—TUBB2B—Parkin-Ubiquitin Proteasomal System pathway—FBXW7—uterine cancer	0.00202	0.0114	CbGpPWpGaD
Ixabepilone—TUBB4B—Chaperonin-mediated protein folding—FBXW7—uterine cancer	0.00202	0.0114	CbGpPWpGaD
Ixabepilone—TUBB4A—Protein folding—FBXW7—uterine cancer	0.00201	0.0113	CbGpPWpGaD
Ixabepilone—TUBB—Parkin-Ubiquitin Proteasomal System pathway—FBXW7—uterine cancer	0.002	0.0113	CbGpPWpGaD
Ixabepilone—TUBB3—Parkin-Ubiquitin Proteasomal System pathway—FBXW7—uterine cancer	0.00195	0.011	CbGpPWpGaD
Ixabepilone—TUBB4A—Loss of Nlp from mitotic centrosomes—YWHAE—uterine cancer	0.00193	0.0109	CbGpPWpGaD
Ixabepilone—TUBB—Regulation of PLK1 Activity at G2/M Transition—YWHAE—uterine cancer	0.0019	0.0107	CbGpPWpGaD
Ixabepilone—TUBB2A—Parkin-Ubiquitin Proteasomal System pathway—FBXW7—uterine cancer	0.00189	0.0107	CbGpPWpGaD
Ixabepilone—TUBB1—Parkin-Ubiquitin Proteasomal System pathway—FBXW7—uterine cancer	0.00185	0.0104	CbGpPWpGaD
Ixabepilone—TUBB4B—Protein folding—FBXW7—uterine cancer	0.00184	0.0104	CbGpPWpGaD
Ixabepilone—TUBB4B—lymph node—uterine cancer	0.00183	0.00661	CbGeAlD
Ixabepilone—TUBB8—Pathogenic Escherichia coli infection—CTNNB1—uterine cancer	0.00182	0.0102	CbGpPWpGaD
Ixabepilone—TUBB2A—Signaling events mediated by HDAC Class II—ESR1—uterine cancer	0.0018	0.0101	CbGpPWpGaD
Ixabepilone—TUBB4B—Loss of Nlp from mitotic centrosomes—YWHAE—uterine cancer	0.00177	0.00997	CbGpPWpGaD
Ixabepilone—TUBB4A—Centrosome maturation—YWHAE—uterine cancer	0.00171	0.00965	CbGpPWpGaD
Ixabepilone—TUBB4A—Parkin-Ubiquitin Proteasomal System pathway—FBXW7—uterine cancer	0.00166	0.00936	CbGpPWpGaD
Ixabepilone—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.00165	0.00928	CbGpPWpGaD
Ixabepilone—CYP3A4—renal system—uterine cancer	0.00161	0.0058	CbGeAlD
Ixabepilone—TUBB4A—Regulation of PLK1 Activity at G2/M Transition—YWHAE—uterine cancer	0.00157	0.00886	CbGpPWpGaD
Ixabepilone—TUBB4B—Centrosome maturation—YWHAE—uterine cancer	0.00157	0.00883	CbGpPWpGaD
Ixabepilone—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—FBXW7—uterine cancer	0.00152	0.00856	CbGpPWpGaD
Ixabepilone—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—YWHAE—uterine cancer	0.00144	0.0081	CbGpPWpGaD
Ixabepilone—TUBB—G2/M Transition—YWHAE—uterine cancer	0.00142	0.00803	CbGpPWpGaD
Ixabepilone—TUBB—Mitotic G2-G2/M phases—YWHAE—uterine cancer	0.0014	0.00792	CbGpPWpGaD
Ixabepilone—CYP3A4—female reproductive system—uterine cancer	0.00129	0.00464	CbGeAlD
Ixabepilone—TUBB6—Pathogenic Escherichia coli infection—CDH1—uterine cancer	0.00124	0.00702	CbGpPWpGaD
Ixabepilone—TUBB2B—Pathogenic Escherichia coli infection—CDH1—uterine cancer	0.00124	0.00702	CbGpPWpGaD
Ixabepilone—TUBB—Pathogenic Escherichia coli infection—CDH1—uterine cancer	0.00123	0.00696	CbGpPWpGaD
Ixabepilone—TUBB3—Pathogenic Escherichia coli infection—CDH1—uterine cancer	0.0012	0.00678	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—TSPYL2—uterine cancer	0.00118	0.00667	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—TSPYL2—uterine cancer	0.00118	0.00667	CbGpPWpGaD
Ixabepilone—TUBB4A—G2/M Transition—YWHAE—uterine cancer	0.00118	0.00665	CbGpPWpGaD
Ixabepilone—TUBB2A—Pathogenic Escherichia coli infection—CDH1—uterine cancer	0.00116	0.00656	CbGpPWpGaD
Ixabepilone—TUBB4A—Mitotic G2-G2/M phases—YWHAE—uterine cancer	0.00116	0.00656	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—TSPYL2—uterine cancer	0.00114	0.00645	CbGpPWpGaD
Ixabepilone—TUBB1—Pathogenic Escherichia coli infection—CDH1—uterine cancer	0.00114	0.00642	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—TSPYL2—uterine cancer	0.00111	0.00624	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—TSPYL2—uterine cancer	0.00108	0.0061	CbGpPWpGaD
Ixabepilone—TUBB4B—G2/M Transition—YWHAE—uterine cancer	0.00108	0.00609	CbGpPWpGaD
Ixabepilone—TUBB4B—Mitotic G2-G2/M phases—YWHAE—uterine cancer	0.00106	0.006	CbGpPWpGaD
Ixabepilone—TUBB2A—Signaling events mediated by HDAC Class III—EP300—uterine cancer	0.00105	0.00593	CbGpPWpGaD
Ixabepilone—TUBB4A—Pathogenic Escherichia coli infection—CDH1—uterine cancer	0.00102	0.00576	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—MLH3—uterine cancer	0.00102	0.00574	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—TSPYL2—uterine cancer	0.000972	0.00548	CbGpPWpGaD
Ixabepilone—TUBB4B—Pathogenic Escherichia coli infection—CDH1—uterine cancer	0.000935	0.00527	CbGpPWpGaD
Ixabepilone—Myalgia—Dactinomycin—uterine cancer	0.000919	0.00169	CcSEcCtD
Ixabepilone—TUBB6—Pathogenic Escherichia coli infection—CTNNB1—uterine cancer	0.000919	0.00518	CbGpPWpGaD
Ixabepilone—TUBB2B—Pathogenic Escherichia coli infection—CTNNB1—uterine cancer	0.000919	0.00518	CbGpPWpGaD
Ixabepilone—Hypersensitivity—Progesterone—uterine cancer	0.000919	0.00168	CcSEcCtD
Ixabepilone—Oesophagitis—Epirubicin—uterine cancer	0.000916	0.00168	CcSEcCtD
Ixabepilone—TUBB—Pathogenic Escherichia coli infection—CTNNB1—uterine cancer	0.000911	0.00513	CbGpPWpGaD
Ixabepilone—Asthenia—Progesterone—uterine cancer	0.000894	0.00164	CcSEcCtD
Ixabepilone—Hypoaesthesia—Etoposide—uterine cancer	0.000893	0.00164	CcSEcCtD
Ixabepilone—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000893	0.00164	CcSEcCtD
Ixabepilone—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000893	0.00164	CcSEcCtD
Ixabepilone—Colitis—Doxorubicin—uterine cancer	0.00089	0.00163	CcSEcCtD
Ixabepilone—TUBB4B—Metabolism of proteins—TSPYL2—uterine cancer	0.000889	0.00501	CbGpPWpGaD
Ixabepilone—TUBB3—Pathogenic Escherichia coli infection—CTNNB1—uterine cancer	0.000888	0.005	CbGpPWpGaD
Ixabepilone—Urinary tract disorder—Etoposide—uterine cancer	0.000886	0.00163	CcSEcCtD
Ixabepilone—Skin exfoliation—Doxorubicin—uterine cancer	0.000885	0.00162	CcSEcCtD
Ixabepilone—Pruritus—Progesterone—uterine cancer	0.000882	0.00162	CcSEcCtD
Ixabepilone—Oedema—Dactinomycin—uterine cancer	0.000881	0.00162	CcSEcCtD
Ixabepilone—Urethral disorder—Etoposide—uterine cancer	0.00088	0.00161	CcSEcCtD
Ixabepilone—Infection—Dactinomycin—uterine cancer	0.000875	0.0016	CcSEcCtD
Ixabepilone—Neuropathy—Doxorubicin—uterine cancer	0.00087	0.0016	CcSEcCtD
Ixabepilone—Sepsis—Epirubicin—uterine cancer	0.00087	0.00159	CcSEcCtD
Ixabepilone—Thrombocytopenia—Dactinomycin—uterine cancer	0.000863	0.00158	CcSEcCtD
Ixabepilone—TUBB2A—Pathogenic Escherichia coli infection—CTNNB1—uterine cancer	0.00086	0.00485	CbGpPWpGaD
Ixabepilone—Diarrhoea—Progesterone—uterine cancer	0.000853	0.00156	CcSEcCtD
Ixabepilone—Erythema multiforme—Etoposide—uterine cancer	0.000849	0.00156	CcSEcCtD
Ixabepilone—Oesophagitis—Doxorubicin—uterine cancer	0.000847	0.00155	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—MLH3—uterine cancer	0.000843	0.00475	CbGpPWpGaD
Ixabepilone—TUBB1—Pathogenic Escherichia coli infection—CTNNB1—uterine cancer	0.000841	0.00474	CbGpPWpGaD
Ixabepilone—Anorexia—Dactinomycin—uterine cancer	0.00084	0.00154	CcSEcCtD
Ixabepilone—Eye disorder—Etoposide—uterine cancer	0.000839	0.00154	CcSEcCtD
Ixabepilone—Cardiac disorder—Etoposide—uterine cancer	0.000833	0.00153	CcSEcCtD
Ixabepilone—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000832	0.00153	CcSEcCtD
Ixabepilone—Dizziness—Progesterone—uterine cancer	0.000824	0.00151	CcSEcCtD
Ixabepilone—Angiopathy—Etoposide—uterine cancer	0.000814	0.00149	CcSEcCtD
Ixabepilone—Immune system disorder—Etoposide—uterine cancer	0.000811	0.00149	CcSEcCtD
Ixabepilone—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000811	0.00149	CcSEcCtD
Ixabepilone—Mediastinal disorder—Etoposide—uterine cancer	0.000809	0.00148	CcSEcCtD
Ixabepilone—Chills—Etoposide—uterine cancer	0.000805	0.00148	CcSEcCtD
Ixabepilone—Sepsis—Doxorubicin—uterine cancer	0.000805	0.00147	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000803	0.00147	CcSEcCtD
Ixabepilone—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000799	0.00147	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—NDC80—uterine cancer	0.000796	0.00449	CbGpPWpGaD
Ixabepilone—Alopecia—Etoposide—uterine cancer	0.000793	0.00145	CcSEcCtD
Ixabepilone—Vomiting—Progesterone—uterine cancer	0.000793	0.00145	CcSEcCtD
Ixabepilone—Rash—Progesterone—uterine cancer	0.000786	0.00144	CcSEcCtD
Ixabepilone—Dermatitis—Progesterone—uterine cancer	0.000785	0.00144	CcSEcCtD
Ixabepilone—Headache—Progesterone—uterine cancer	0.000781	0.00143	CcSEcCtD
Ixabepilone—Hot flush—Epirubicin—uterine cancer	0.000778	0.00143	CcSEcCtD
Ixabepilone—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000773	0.00142	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—MLH3—uterine cancer	0.000771	0.00435	CbGpPWpGaD
Ixabepilone—Menopausal symptoms—Epirubicin—uterine cancer	0.000771	0.00141	CcSEcCtD
Ixabepilone—Decreased appetite—Dactinomycin—uterine cancer	0.000766	0.0014	CcSEcCtD
Ixabepilone—Fatigue—Dactinomycin—uterine cancer	0.00076	0.00139	CcSEcCtD
Ixabepilone—TUBB4A—Pathogenic Escherichia coli infection—CTNNB1—uterine cancer	0.000755	0.00425	CbGpPWpGaD
Ixabepilone—Pain—Dactinomycin—uterine cancer	0.000754	0.00138	CcSEcCtD
Ixabepilone—TUBB2A—Signaling events mediated by HDAC Class III—TP53—uterine cancer	0.000753	0.00424	CbGpPWpGaD
Ixabepilone—Muscle spasms—Etoposide—uterine cancer	0.000751	0.00138	CcSEcCtD
Ixabepilone—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000747	0.00137	CcSEcCtD
Ixabepilone—Lethargy—Epirubicin—uterine cancer	0.000742	0.00136	CcSEcCtD
Ixabepilone—Nausea—Progesterone—uterine cancer	0.000741	0.00136	CcSEcCtD
Ixabepilone—Hyponatraemia—Epirubicin—uterine cancer	0.00073	0.00134	CcSEcCtD
Ixabepilone—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000727	0.00133	CcSEcCtD
Ixabepilone—Anaemia—Etoposide—uterine cancer	0.000722	0.00132	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000721	0.00132	CcSEcCtD
Ixabepilone—Hot flush—Doxorubicin—uterine cancer	0.000719	0.00132	CcSEcCtD
Ixabepilone—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000718	0.00132	CcSEcCtD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000714	0.00402	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000714	0.00402	CbGpPWpGaD
Ixabepilone—Menopausal symptoms—Doxorubicin—uterine cancer	0.000713	0.00131	CcSEcCtD
Ixabepilone—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000712	0.00131	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—NDC80—uterine cancer	0.000712	0.00401	CbGpPWpGaD
Ixabepilone—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000712	0.0013	CcSEcCtD
Ixabepilone—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000708	0.0013	CcSEcCtD
Ixabepilone—Leukopenia—Etoposide—uterine cancer	0.000699	0.00128	CcSEcCtD
Ixabepilone—Body temperature increased—Dactinomycin—uterine cancer	0.000697	0.00128	CcSEcCtD
Ixabepilone—Abdominal pain—Dactinomycin—uterine cancer	0.000697	0.00128	CcSEcCtD
Ixabepilone—TUBB4B—Pathogenic Escherichia coli infection—CTNNB1—uterine cancer	0.00069	0.00389	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000689	0.00389	CbGpPWpGaD
Ixabepilone—Loss of consciousness—Etoposide—uterine cancer	0.000687	0.00126	CcSEcCtD
Ixabepilone—Lethargy—Doxorubicin—uterine cancer	0.000687	0.00126	CcSEcCtD
Ixabepilone—Cough—Etoposide—uterine cancer	0.000682	0.00125	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—POLD1—uterine cancer	0.000677	0.00382	CbGpPWpGaD
Ixabepilone—Dehydration—Epirubicin—uterine cancer	0.000676	0.00124	CcSEcCtD
Ixabepilone—Hyponatraemia—Doxorubicin—uterine cancer	0.000676	0.00124	CcSEcCtD
Ixabepilone—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000673	0.00123	CcSEcCtD
Ixabepilone—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000671	0.00123	CcSEcCtD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000668	0.00376	CbGpPWpGaD
Ixabepilone—Chest pain—Etoposide—uterine cancer	0.000665	0.00122	CcSEcCtD
Ixabepilone—Hypokalaemia—Epirubicin—uterine cancer	0.000662	0.00121	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000661	0.00121	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—NDC80—uterine cancer	0.00066	0.00372	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000653	0.00368	CbGpPWpGaD
Ixabepilone—Hypersensitivity—Dactinomycin—uterine cancer	0.000649	0.00119	CcSEcCtD
Ixabepilone—Gastritis—Epirubicin—uterine cancer	0.000644	0.00118	CcSEcCtD
Ixabepilone—Muscular weakness—Epirubicin—uterine cancer	0.000642	0.00118	CcSEcCtD
Ixabepilone—Infection—Etoposide—uterine cancer	0.000634	0.00116	CcSEcCtD
Ixabepilone—Asthenia—Dactinomycin—uterine cancer	0.000632	0.00116	CcSEcCtD
Ixabepilone—Dysphagia—Epirubicin—uterine cancer	0.000629	0.00115	CcSEcCtD
Ixabepilone—Dehydration—Doxorubicin—uterine cancer	0.000626	0.00115	CcSEcCtD
Ixabepilone—Thrombocytopenia—Etoposide—uterine cancer	0.000624	0.00114	CcSEcCtD
Ixabepilone—Skin disorder—Etoposide—uterine cancer	0.000619	0.00114	CcSEcCtD
Ixabepilone—Hypokalaemia—Doxorubicin—uterine cancer	0.000612	0.00112	CcSEcCtD
Ixabepilone—Angina pectoris—Epirubicin—uterine cancer	0.000612	0.00112	CcSEcCtD
Ixabepilone—Anorexia—Etoposide—uterine cancer	0.000608	0.00111	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—POLD1—uterine cancer	0.000605	0.00341	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—NDC80—uterine cancer	0.000603	0.0034	CbGpPWpGaD
Ixabepilone—Diarrhoea—Dactinomycin—uterine cancer	0.000603	0.00111	CcSEcCtD
Ixabepilone—Pancytopenia—Epirubicin—uterine cancer	0.000597	0.00109	CcSEcCtD
Ixabepilone—Hypotension—Etoposide—uterine cancer	0.000596	0.00109	CcSEcCtD
Ixabepilone—Gastritis—Doxorubicin—uterine cancer	0.000596	0.00109	CcSEcCtD
Ixabepilone—Muscular weakness—Doxorubicin—uterine cancer	0.000594	0.00109	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—NDC80—uterine cancer	0.00059	0.00332	CbGpPWpGaD
Ixabepilone—Neutropenia—Epirubicin—uterine cancer	0.000588	0.00108	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000586	0.0033	CbGpPWpGaD
Ixabepilone—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000584	0.00107	CcSEcCtD
Ixabepilone—Dysphagia—Doxorubicin—uterine cancer	0.000582	0.00107	CcSEcCtD
Ixabepilone—Paraesthesia—Etoposide—uterine cancer	0.000573	0.00105	CcSEcCtD
Ixabepilone—Weight decreased—Epirubicin—uterine cancer	0.000569	0.00104	CcSEcCtD
Ixabepilone—Dyspnoea—Etoposide—uterine cancer	0.000569	0.00104	CcSEcCtD
Ixabepilone—Angina pectoris—Doxorubicin—uterine cancer	0.000567	0.00104	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—RRM2—uterine cancer	0.000564	0.00318	CbGpPWpGaD
Ixabepilone—Pneumonia—Epirubicin—uterine cancer	0.000564	0.00103	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—POLD1—uterine cancer	0.000561	0.00316	CbGpPWpGaD
Ixabepilone—Infestation NOS—Epirubicin—uterine cancer	0.000561	0.00103	CcSEcCtD
Ixabepilone—Infestation—Epirubicin—uterine cancer	0.000561	0.00103	CcSEcCtD
Ixabepilone—Vomiting—Dactinomycin—uterine cancer	0.00056	0.00103	CcSEcCtD
Ixabepilone—Rash—Dactinomycin—uterine cancer	0.000556	0.00102	CcSEcCtD
Ixabepilone—Decreased appetite—Etoposide—uterine cancer	0.000554	0.00102	CcSEcCtD
Ixabepilone—Pancytopenia—Doxorubicin—uterine cancer	0.000552	0.00101	CcSEcCtD
Ixabepilone—Renal failure—Epirubicin—uterine cancer	0.000551	0.00101	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Etoposide—uterine cancer	0.000551	0.00101	CcSEcCtD
Ixabepilone—Fatigue—Etoposide—uterine cancer	0.00055	0.00101	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Epirubicin—uterine cancer	0.000549	0.00101	CcSEcCtD
Ixabepilone—Jaundice—Epirubicin—uterine cancer	0.000546	0.001	CcSEcCtD
Ixabepilone—Stomatitis—Epirubicin—uterine cancer	0.000546	0.001	CcSEcCtD
Ixabepilone—Pain—Etoposide—uterine cancer	0.000545	0.001	CcSEcCtD
Ixabepilone—Constipation—Etoposide—uterine cancer	0.000545	0.001	CcSEcCtD
Ixabepilone—Urinary tract infection—Epirubicin—uterine cancer	0.000545	0.000999	CcSEcCtD
Ixabepilone—Neutropenia—Doxorubicin—uterine cancer	0.000544	0.000997	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000541	0.000991	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—NDC80—uterine cancer	0.000539	0.00304	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000536	0.00302	CbGpPWpGaD
Ixabepilone—Hepatobiliary disease—Epirubicin—uterine cancer	0.00053	0.000972	CcSEcCtD
Ixabepilone—TUBB2B—Metabolism of proteins—INHBA—uterine cancer	0.000529	0.00298	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—INHBA—uterine cancer	0.000529	0.00298	CbGpPWpGaD
Ixabepilone—Weight decreased—Doxorubicin—uterine cancer	0.000526	0.000965	CcSEcCtD
Ixabepilone—Nausea—Dactinomycin—uterine cancer	0.000523	0.00096	CcSEcCtD
Ixabepilone—Pneumonia—Doxorubicin—uterine cancer	0.000522	0.000956	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Etoposide—uterine cancer	0.000522	0.000956	CcSEcCtD
Ixabepilone—Infestation NOS—Doxorubicin—uterine cancer	0.000519	0.000951	CcSEcCtD
Ixabepilone—Infestation—Doxorubicin—uterine cancer	0.000519	0.000951	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—POLD1—uterine cancer	0.000513	0.00289	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—INHBA—uterine cancer	0.000511	0.00288	CbGpPWpGaD
Ixabepilone—Renal failure—Doxorubicin—uterine cancer	0.00051	0.000935	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000508	0.000932	CcSEcCtD
Ixabepilone—Haemoglobin—Epirubicin—uterine cancer	0.000506	0.000927	CcSEcCtD
Ixabepilone—Jaundice—Doxorubicin—uterine cancer	0.000506	0.000927	CcSEcCtD
Ixabepilone—Stomatitis—Doxorubicin—uterine cancer	0.000506	0.000927	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—RRM2—uterine cancer	0.000505	0.00284	CbGpPWpGaD
Ixabepilone—Body temperature increased—Etoposide—uterine cancer	0.000504	0.000924	CcSEcCtD
Ixabepilone—Abdominal pain—Etoposide—uterine cancer	0.000504	0.000924	CcSEcCtD
Ixabepilone—Urinary tract infection—Doxorubicin—uterine cancer	0.000504	0.000924	CcSEcCtD
Ixabepilone—Haemorrhage—Epirubicin—uterine cancer	0.000503	0.000922	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—POLD1—uterine cancer	0.000501	0.00283	CbGpPWpGaD
Ixabepilone—Hypoaesthesia—Epirubicin—uterine cancer	0.000501	0.000918	CcSEcCtD
Ixabepilone—TUBB2B—Metabolism of proteins—MME—uterine cancer	0.000497	0.0028	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—MME—uterine cancer	0.000497	0.0028	CbGpPWpGaD
Ixabepilone—Urinary tract disorder—Epirubicin—uterine cancer	0.000497	0.000911	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—INHBA—uterine cancer	0.000495	0.00279	CbGpPWpGaD
Ixabepilone—Connective tissue disorder—Epirubicin—uterine cancer	0.000494	0.000907	CcSEcCtD
Ixabepilone—Urethral disorder—Epirubicin—uterine cancer	0.000493	0.000904	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000491	0.000899	CcSEcCtD
Ixabepilone—TUBB1—Metabolism of proteins—INHBA—uterine cancer	0.000484	0.00273	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—MME—uterine cancer	0.00048	0.00271	CbGpPWpGaD
Ixabepilone—TUBB—G2/M Transition—EP300—uterine cancer	0.000476	0.00268	CbGpPWpGaD
Ixabepilone—Erythema multiforme—Epirubicin—uterine cancer	0.000476	0.000872	CcSEcCtD
Ixabepilone—Eye disorder—Epirubicin—uterine cancer	0.00047	0.000862	CcSEcCtD
Ixabepilone—Hypersensitivity—Etoposide—uterine cancer	0.00047	0.000861	CcSEcCtD
Ixabepilone—TUBB—Mitotic G2-G2/M phases—EP300—uterine cancer	0.000469	0.00265	CbGpPWpGaD
Ixabepilone—Haemoglobin—Doxorubicin—uterine cancer	0.000468	0.000858	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—RRM2—uterine cancer	0.000468	0.00264	CbGpPWpGaD
Ixabepilone—Cardiac disorder—Epirubicin—uterine cancer	0.000467	0.000856	CcSEcCtD
Ixabepilone—Haemorrhage—Doxorubicin—uterine cancer	0.000466	0.000854	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—MME—uterine cancer	0.000465	0.00262	CbGpPWpGaD
Ixabepilone—Hypoaesthesia—Doxorubicin—uterine cancer	0.000463	0.000849	CcSEcCtD
Ixabepilone—Urinary tract disorder—Doxorubicin—uterine cancer	0.00046	0.000843	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—POLD1—uterine cancer	0.000459	0.00259	CbGpPWpGaD
Ixabepilone—Asthenia—Etoposide—uterine cancer	0.000458	0.000839	CcSEcCtD
Ixabepilone—Connective tissue disorder—Doxorubicin—uterine cancer	0.000458	0.000839	CcSEcCtD
Ixabepilone—Angiopathy—Epirubicin—uterine cancer	0.000457	0.000837	CcSEcCtD
Ixabepilone—Urethral disorder—Doxorubicin—uterine cancer	0.000456	0.000837	CcSEcCtD
Ixabepilone—TUBB1—Metabolism of proteins—MME—uterine cancer	0.000455	0.00256	CbGpPWpGaD
Ixabepilone—Immune system disorder—Epirubicin—uterine cancer	0.000454	0.000833	CcSEcCtD
Ixabepilone—Mediastinal disorder—Epirubicin—uterine cancer	0.000453	0.000831	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—YWHAE—uterine cancer	0.000453	0.00255	CbGpPWpGaD
Ixabepilone—Chills—Epirubicin—uterine cancer	0.000451	0.000828	CcSEcCtD
Ixabepilone—Pruritus—Etoposide—uterine cancer	0.000451	0.000827	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—MLH1—uterine cancer	0.000448	0.00253	CbGpPWpGaD
Ixabepilone—Alopecia—Epirubicin—uterine cancer	0.000445	0.000815	CcSEcCtD
Ixabepilone—Mental disorder—Epirubicin—uterine cancer	0.000441	0.000808	CcSEcCtD
Ixabepilone—Erythema multiforme—Doxorubicin—uterine cancer	0.00044	0.000807	CcSEcCtD
Ixabepilone—Malnutrition—Epirubicin—uterine cancer	0.000438	0.000803	CcSEcCtD
Ixabepilone—Diarrhoea—Etoposide—uterine cancer	0.000436	0.0008	CcSEcCtD
Ixabepilone—Eye disorder—Doxorubicin—uterine cancer	0.000435	0.000798	CcSEcCtD
Ixabepilone—TUBB4A—Metabolism of proteins—INHBA—uterine cancer	0.000434	0.00245	CbGpPWpGaD
Ixabepilone—Cardiac disorder—Doxorubicin—uterine cancer	0.000432	0.000792	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—RRM2—uterine cancer	0.000428	0.00241	CbGpPWpGaD
Ixabepilone—Angiopathy—Doxorubicin—uterine cancer	0.000422	0.000774	CcSEcCtD
Ixabepilone—Dizziness—Etoposide—uterine cancer	0.000422	0.000773	CcSEcCtD
Ixabepilone—Muscle spasms—Epirubicin—uterine cancer	0.000421	0.000772	CcSEcCtD
Ixabepilone—Immune system disorder—Doxorubicin—uterine cancer	0.000421	0.000771	CcSEcCtD
Ixabepilone—Mediastinal disorder—Doxorubicin—uterine cancer	0.00042	0.000769	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—RRM2—uterine cancer	0.000418	0.00236	CbGpPWpGaD
Ixabepilone—Chills—Doxorubicin—uterine cancer	0.000418	0.000766	CcSEcCtD
Ixabepilone—Alopecia—Doxorubicin—uterine cancer	0.000411	0.000754	CcSEcCtD
Ixabepilone—TUBB4A—Metabolism of proteins—MME—uterine cancer	0.000408	0.0023	CbGpPWpGaD
Ixabepilone—Mental disorder—Doxorubicin—uterine cancer	0.000408	0.000748	CcSEcCtD
Ixabepilone—Vomiting—Etoposide—uterine cancer	0.000405	0.000743	CcSEcCtD
Ixabepilone—Malnutrition—Doxorubicin—uterine cancer	0.000405	0.000743	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—YWHAE—uterine cancer	0.000405	0.00228	CbGpPWpGaD
Ixabepilone—Anaemia—Epirubicin—uterine cancer	0.000405	0.000742	CcSEcCtD
Ixabepilone—Rash—Etoposide—uterine cancer	0.000402	0.000737	CcSEcCtD
Ixabepilone—Dermatitis—Etoposide—uterine cancer	0.000402	0.000737	CcSEcCtD
Ixabepilone—Headache—Etoposide—uterine cancer	0.0004	0.000732	CcSEcCtD
Ixabepilone—TUBB4B—Metabolism of proteins—INHBA—uterine cancer	0.000397	0.00224	CbGpPWpGaD
Ixabepilone—TUBB4A—G2/M Transition—EP300—uterine cancer	0.000394	0.00222	CbGpPWpGaD
Ixabepilone—Syncope—Epirubicin—uterine cancer	0.000393	0.00072	CcSEcCtD
Ixabepilone—Leukopenia—Epirubicin—uterine cancer	0.000392	0.000719	CcSEcCtD
Ixabepilone—Muscle spasms—Doxorubicin—uterine cancer	0.00039	0.000714	CcSEcCtD
Ixabepilone—TUBB4A—Mitotic G2-G2/M phases—EP300—uterine cancer	0.000389	0.00219	CbGpPWpGaD
Ixabepilone—Loss of consciousness—Epirubicin—uterine cancer	0.000385	0.000706	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—RRM2—uterine cancer	0.000382	0.00216	CbGpPWpGaD
Ixabepilone—Cough—Epirubicin—uterine cancer	0.000382	0.000701	CcSEcCtD
Ixabepilone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000382	0.00215	CbGpPWpGaD
Ixabepilone—Nausea—Etoposide—uterine cancer	0.000379	0.000694	CcSEcCtD
Ixabepilone—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000377	0.00213	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—YWHAE—uterine cancer	0.000375	0.00212	CbGpPWpGaD
Ixabepilone—Anaemia—Doxorubicin—uterine cancer	0.000375	0.000687	CcSEcCtD
Ixabepilone—TUBB4B—Metabolism of proteins—MME—uterine cancer	0.000373	0.00211	CbGpPWpGaD
Ixabepilone—Myalgia—Epirubicin—uterine cancer	0.000373	0.000684	CcSEcCtD
Ixabepilone—Chest pain—Epirubicin—uterine cancer	0.000373	0.000684	CcSEcCtD
Ixabepilone—Arthralgia—Epirubicin—uterine cancer	0.000373	0.000684	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—MLH1—uterine cancer	0.000371	0.00209	CbGpPWpGaD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.00037	0.000679	CcSEcCtD
Ixabepilone—Syncope—Doxorubicin—uterine cancer	0.000363	0.000666	CcSEcCtD
Ixabepilone—Leukopenia—Doxorubicin—uterine cancer	0.000363	0.000665	CcSEcCtD
Ixabepilone—TUBB4B—G2/M Transition—EP300—uterine cancer	0.000361	0.00203	CbGpPWpGaD
Ixabepilone—Oedema—Epirubicin—uterine cancer	0.000357	0.000655	CcSEcCtD
Ixabepilone—Loss of consciousness—Doxorubicin—uterine cancer	0.000356	0.000653	CcSEcCtD
Ixabepilone—TUBB4B—Mitotic G2-G2/M phases—EP300—uterine cancer	0.000356	0.002	CbGpPWpGaD
Ixabepilone—Infection—Epirubicin—uterine cancer	0.000355	0.000651	CcSEcCtD
Ixabepilone—Cough—Doxorubicin—uterine cancer	0.000354	0.000648	CcSEcCtD
Ixabepilone—Shock—Epirubicin—uterine cancer	0.000352	0.000645	CcSEcCtD
Ixabepilone—Nervous system disorder—Epirubicin—uterine cancer	0.000351	0.000643	CcSEcCtD
Ixabepilone—Thrombocytopenia—Epirubicin—uterine cancer	0.00035	0.000642	CcSEcCtD
Ixabepilone—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.000348	0.00196	CbGpPWpGaD
Ixabepilone—Skin disorder—Epirubicin—uterine cancer	0.000347	0.000637	CcSEcCtD
Ixabepilone—Chest pain—Doxorubicin—uterine cancer	0.000345	0.000633	CcSEcCtD
Ixabepilone—Myalgia—Doxorubicin—uterine cancer	0.000345	0.000633	CcSEcCtD
Ixabepilone—Arthralgia—Doxorubicin—uterine cancer	0.000345	0.000633	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—YWHAE—uterine cancer	0.000343	0.00194	CbGpPWpGaD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000343	0.000628	CcSEcCtD
Ixabepilone—Anorexia—Epirubicin—uterine cancer	0.000341	0.000625	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDKN2B—uterine cancer	0.00034	0.00192	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—MLH1—uterine cancer	0.00034	0.00191	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—YWHAE—uterine cancer	0.000336	0.00189	CbGpPWpGaD
Ixabepilone—Hypotension—Epirubicin—uterine cancer	0.000334	0.000612	CcSEcCtD
Ixabepilone—Oedema—Doxorubicin—uterine cancer	0.000331	0.000606	CcSEcCtD
Ixabepilone—Infection—Doxorubicin—uterine cancer	0.000329	0.000602	CcSEcCtD
Ixabepilone—TUBB6—Metabolism of proteins—FBXW7—uterine cancer	0.000327	0.00184	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—FBXW7—uterine cancer	0.000327	0.00184	CbGpPWpGaD
Ixabepilone—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000326	0.000597	CcSEcCtD
Ixabepilone—Shock—Doxorubicin—uterine cancer	0.000325	0.000597	CcSEcCtD
Ixabepilone—Nervous system disorder—Doxorubicin—uterine cancer	0.000324	0.000595	CcSEcCtD
Ixabepilone—Thrombocytopenia—Doxorubicin—uterine cancer	0.000324	0.000594	CcSEcCtD
Ixabepilone—Insomnia—Epirubicin—uterine cancer	0.000323	0.000593	CcSEcCtD
Ixabepilone—Skin disorder—Doxorubicin—uterine cancer	0.000321	0.000589	CcSEcCtD
Ixabepilone—Paraesthesia—Epirubicin—uterine cancer	0.000321	0.000588	CcSEcCtD
Ixabepilone—Dyspnoea—Epirubicin—uterine cancer	0.000319	0.000584	CcSEcCtD
Ixabepilone—TUBB3—Metabolism of proteins—FBXW7—uterine cancer	0.000316	0.00178	CbGpPWpGaD
Ixabepilone—Anorexia—Doxorubicin—uterine cancer	0.000315	0.000578	CcSEcCtD
Ixabepilone—Decreased appetite—Epirubicin—uterine cancer	0.000311	0.00057	CcSEcCtD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.00031	0.00175	CbGpPWpGaD
Ixabepilone—Hypotension—Doxorubicin—uterine cancer	0.000309	0.000567	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000309	0.000566	CcSEcCtD
Ixabepilone—Fatigue—Epirubicin—uterine cancer	0.000308	0.000565	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—YWHAE—uterine cancer	0.000307	0.00173	CbGpPWpGaD
Ixabepilone—Constipation—Epirubicin—uterine cancer	0.000306	0.00056	CcSEcCtD
Ixabepilone—Pain—Epirubicin—uterine cancer	0.000306	0.00056	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—FBXW7—uterine cancer	0.000306	0.00172	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDKN2B—uterine cancer	0.000304	0.00172	CbGpPWpGaD
Ixabepilone—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000301	0.000552	CcSEcCtD
Ixabepilone—Insomnia—Doxorubicin—uterine cancer	0.000299	0.000548	CcSEcCtD
Ixabepilone—TUBB1—Metabolism of proteins—FBXW7—uterine cancer	0.000299	0.00168	CbGpPWpGaD
Ixabepilone—Paraesthesia—Doxorubicin—uterine cancer	0.000297	0.000545	CcSEcCtD
Ixabepilone—Dyspnoea—Doxorubicin—uterine cancer	0.000295	0.000541	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—BIRC5—uterine cancer	0.000294	0.00166	CbGpPWpGaD
Ixabepilone—Gastrointestinal pain—Epirubicin—uterine cancer	0.000292	0.000536	CcSEcCtD
Ixabepilone—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	0.000292	0.00164	CbGpPWpGaD
Ixabepilone—Decreased appetite—Doxorubicin—uterine cancer	0.000288	0.000527	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000286	0.000524	CcSEcCtD
Ixabepilone—Fatigue—Doxorubicin—uterine cancer	0.000285	0.000523	CcSEcCtD
Ixabepilone—Pain—Doxorubicin—uterine cancer	0.000283	0.000519	CcSEcCtD
Ixabepilone—Constipation—Doxorubicin—uterine cancer	0.000283	0.000519	CcSEcCtD
Ixabepilone—Body temperature increased—Epirubicin—uterine cancer	0.000283	0.000518	CcSEcCtD
Ixabepilone—Abdominal pain—Epirubicin—uterine cancer	0.000283	0.000518	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDKN2B—uterine cancer	0.000282	0.00159	CbGpPWpGaD
Ixabepilone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000281	0.00158	CbGpPWpGaD
Ixabepilone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000277	0.00156	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	0.000271	0.00153	CbGpPWpGaD
Ixabepilone—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00027	0.000496	CcSEcCtD
Ixabepilone—TUBB4A—Metabolism of proteins—FBXW7—uterine cancer	0.000268	0.00151	CbGpPWpGaD
Ixabepilone—Hypersensitivity—Epirubicin—uterine cancer	0.000263	0.000483	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—BIRC5—uterine cancer	0.000263	0.00148	CbGpPWpGaD
Ixabepilone—Body temperature increased—Doxorubicin—uterine cancer	0.000261	0.000479	CcSEcCtD
Ixabepilone—Abdominal pain—Doxorubicin—uterine cancer	0.000261	0.000479	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDKN2B—uterine cancer	0.000258	0.00145	CbGpPWpGaD
Ixabepilone—Asthenia—Epirubicin—uterine cancer	0.000256	0.00047	CcSEcCtD
Ixabepilone—Pruritus—Epirubicin—uterine cancer	0.000253	0.000464	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—CDKN2B—uterine cancer	0.000252	0.00142	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—FBXW7—uterine cancer	0.000245	0.00138	CbGpPWpGaD
Ixabepilone—Diarrhoea—Epirubicin—uterine cancer	0.000245	0.000448	CcSEcCtD
Ixabepilone—Hypersensitivity—Doxorubicin—uterine cancer	0.000244	0.000447	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—BIRC5—uterine cancer	0.000243	0.00137	CbGpPWpGaD
Ixabepilone—Asthenia—Doxorubicin—uterine cancer	0.000237	0.000435	CcSEcCtD
Ixabepilone—Dizziness—Epirubicin—uterine cancer	0.000236	0.000433	CcSEcCtD
Ixabepilone—Pruritus—Doxorubicin—uterine cancer	0.000234	0.000429	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—CDKN2B—uterine cancer	0.000231	0.0013	CbGpPWpGaD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000228	0.00128	CbGpPWpGaD
Ixabepilone—Vomiting—Epirubicin—uterine cancer	0.000227	0.000417	CcSEcCtD
Ixabepilone—Diarrhoea—Doxorubicin—uterine cancer	0.000226	0.000415	CcSEcCtD
Ixabepilone—Rash—Epirubicin—uterine cancer	0.000225	0.000413	CcSEcCtD
Ixabepilone—Dermatitis—Epirubicin—uterine cancer	0.000225	0.000413	CcSEcCtD
Ixabepilone—Headache—Epirubicin—uterine cancer	0.000224	0.000411	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—BIRC5—uterine cancer	0.000223	0.00125	CbGpPWpGaD
Ixabepilone—Dizziness—Doxorubicin—uterine cancer	0.000219	0.000401	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—BIRC5—uterine cancer	0.000218	0.00123	CbGpPWpGaD
Ixabepilone—Nausea—Epirubicin—uterine cancer	0.000212	0.000389	CcSEcCtD
Ixabepilone—Vomiting—Doxorubicin—uterine cancer	0.00021	0.000386	CcSEcCtD
Ixabepilone—Rash—Doxorubicin—uterine cancer	0.000209	0.000382	CcSEcCtD
Ixabepilone—Dermatitis—Doxorubicin—uterine cancer	0.000208	0.000382	CcSEcCtD
Ixabepilone—Headache—Doxorubicin—uterine cancer	0.000207	0.00038	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—BIRC5—uterine cancer	0.000199	0.00112	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	0.000199	0.00112	CbGpPWpGaD
Ixabepilone—Nausea—Doxorubicin—uterine cancer	0.000196	0.00036	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDKN2A—uterine cancer	0.000195	0.0011	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	0.000175	0.000985	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDKN2A—uterine cancer	0.000174	0.000981	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDKN1B—uterine cancer	0.000172	0.000972	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—CCL2—uterine cancer	0.000168	0.000947	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—CCL2—uterine cancer	0.000168	0.000947	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	0.000164	0.000927	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	0.000162	0.000915	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—CCL2—uterine cancer	0.000162	0.000914	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDKN2A—uterine cancer	0.000161	0.000909	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—CCL2—uterine cancer	0.000157	0.000885	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDKN1B—uterine cancer	0.000154	0.000869	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—CCL2—uterine cancer	0.000154	0.000866	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	0.000153	0.000864	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—EP300—uterine cancer	0.000151	0.000853	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDKN2A—uterine cancer	0.000148	0.000832	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDKN2A—uterine cancer	0.000144	0.000813	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDKN1B—uterine cancer	0.000143	0.000805	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—CCL2—uterine cancer	0.000138	0.000777	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—EP300—uterine cancer	0.000135	0.000763	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—CXCL8—uterine cancer	0.000133	0.000748	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—CXCL8—uterine cancer	0.000133	0.000748	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDKN2A—uterine cancer	0.000132	0.000744	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDKN1B—uterine cancer	0.000131	0.000736	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—CXCL8—uterine cancer	0.000128	0.000723	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDKN1B—uterine cancer	0.000128	0.00072	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—CCL2—uterine cancer	0.000126	0.000711	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—EP300—uterine cancer	0.000125	0.000707	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—CXCL8—uterine cancer	0.000124	0.0007	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—CTNNB1—uterine cancer	0.000122	0.00069	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—CTNNB1—uterine cancer	0.000122	0.00069	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—CXCL8—uterine cancer	0.000121	0.000684	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	0.000121	0.000682	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	0.000119	0.000673	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—CTNNB1—uterine cancer	0.000118	0.000667	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDKN1B—uterine cancer	0.000117	0.000659	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—EP300—uterine cancer	0.000115	0.000647	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—CTNNB1—uterine cancer	0.000115	0.000646	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—EP300—uterine cancer	0.000112	0.000632	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—CTNNB1—uterine cancer	0.000112	0.000632	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—CXCL8—uterine cancer	0.000109	0.000615	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—EP300—uterine cancer	0.000103	0.000578	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—CTNNB1—uterine cancer	0.000101	0.000567	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—CXCL8—uterine cancer	9.97e-05	0.000562	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—TP53—uterine cancer	9.69e-05	0.000546	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—CTNNB1—uterine cancer	9.2e-05	0.000519	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TP53—uterine cancer	8.03e-05	0.000452	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TP53—uterine cancer	7.34e-05	0.000414	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SRD5A2—uterine cancer	6.5e-05	0.000367	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NDUFB11—uterine cancer	6.5e-05	0.000367	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—AKR1B1—uterine cancer	4.7e-05	0.000265	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—STAR—uterine cancer	4.7e-05	0.000265	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—POLD1—uterine cancer	3.69e-05	0.000208	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—AKR1C1—uterine cancer	3.45e-05	0.000195	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—RRM2—uterine cancer	3.08e-05	0.000173	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—DCN—uterine cancer	2.99e-05	0.000168	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP11A1—uterine cancer	2.81e-05	0.000159	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—AKR1C3—uterine cancer	2.66e-05	0.00015	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—STK11—uterine cancer	2.07e-05	0.000117	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP19A1—uterine cancer	2.07e-05	0.000117	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—MTHFR—uterine cancer	1.56e-05	8.77e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PTEN—uterine cancer	8.65e-06	4.88e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—EP300—uterine cancer	8.25e-06	4.65e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CA—uterine cancer	6.1e-06	3.44e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—AKT1—uterine cancer	4.99e-06	2.81e-05	CbGpPWpGaD
